BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 29045541)

  • 1. From hepatitis C virus infection to B-cell lymphoma.
    Couronné L; Bachy E; Roulland S; Nadel B; Davi F; Armand M; Canioni D; Michot JM; Visco C; Arcaini L; Besson C; Hermine O
    Ann Oncol; 2018 Jan; 29(1):92-100. PubMed ID: 29045541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus infection and lymphoma.
    Bachy E; Besson C; Suarez F; Hermine O
    Mediterr J Hematol Infect Dis; 2010 Mar; 2(1):e2010004. PubMed ID: 21415946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C virus - associated B cell non-Hodgkin's lymphoma.
    Mihăilă RG
    World J Gastroenterol; 2016 Jul; 22(27):6214-23. PubMed ID: 27468211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C-associated B-cell non-Hodgkin lymphomas. Epidemiology, molecular signature and clinical management.
    Peveling-Oberhag J; Arcaini L; Hansmann ML; Zeuzem S
    J Hepatol; 2013 Jul; 59(1):169-77. PubMed ID: 23542089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HCV-associated lymphomas.
    Fiorilli M; Mecucci C; Farci P; Casato M
    Rev Clin Exp Hematol; 2003 Dec; 7(4):406-23. PubMed ID: 15129650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C Virus-Associated B-Cell Non-Hodgkin's Lymphoma: Clinical and Therapeutic Challenges.
    Russi S; Sansonno L; Sansonno D
    Curr Drug Targets; 2017; 18(7):766-771. PubMed ID: 26844565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus (HCV) and lymphomagenesis.
    Weng WK; Levy S
    Leuk Lymphoma; 2003 Jul; 44(7):1113-20. PubMed ID: 12916862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus - Associated marginal zone lymphoma.
    Armand M; Besson C; Hermine O; Davi F
    Best Pract Res Clin Haematol; 2017; 30(1-2):41-49. PubMed ID: 28288715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus-associated B-cell lymphomas: The importance of the new direct antiviral agent therapy.
    Mazzaro C; Bomben R; Gragnani L; Visentini M; Pozzato G; Pozzo F; Zucchetto A; Gattei V
    Semin Hematol; 2022 Oct; 59(4):177-182. PubMed ID: 36805885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The anti-lymphoma activity of antiviral therapy in HCV-associated B-cell non-Hodgkin lymphomas: a meta-analysis.
    Peveling-Oberhag J; Arcaini L; Bankov K; Zeuzem S; Herrmann E
    J Viral Hepat; 2016 Jul; 23(7):536-44. PubMed ID: 26924533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HCV infection and non-Hodgkin lymphomas: an evolving story.
    Defrancesco I; Zerbi C; Rattotti S; Merli M; Bruno R; Paulli M; Arcaini L
    Clin Exp Med; 2020 Aug; 20(3):321-328. PubMed ID: 32052244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus infection and non-hepatocellular malignancies in the DAA era: A systematic review and meta-analysis.
    Masarone M; Persico M
    Liver Int; 2019 Jul; 39(7):1292-1306. PubMed ID: 30983083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C Virus-Associated Non-Hodgkin Lymphomas: Biology, Epidemiology, and Treatment.
    Pozzato G; Mazzaro C; Gattei V
    Clin Liver Dis; 2017 Aug; 21(3):499-515. PubMed ID: 28689589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HCV-related lymphoproliferative disorders in the direct-acting antiviral era: From mixed cryoglobulinaemia to B-cell lymphoma.
    Cacoub P; Comarmond C; Vieira M; Régnier P; Saadoun D
    J Hepatol; 2022 Jan; 76(1):174-185. PubMed ID: 34600000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B-cell lymphomas involving the skin associated with hepatitis C virus infection.
    Viguier M; Rivet J; Agbalika F; Kerviler E; Brice P; Dubertret L; Bachelez H
    Int J Dermatol; 2002 Sep; 41(9):577-82. PubMed ID: 12358827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum-free light chain assessment in hepatitis C virus-related lymphoproliferative disorders.
    Terrier B; Sène D; Saadoun D; Ghillani-Dalbin P; Thibault V; Delluc A; Piette JC; Cacoub P
    Ann Rheum Dis; 2009 Jan; 68(1):89-93. PubMed ID: 18375535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HCV-associated B-cell non-Hodgkin lymphomas and new direct antiviral agents.
    Carrier P; Jaccard A; Jacques J; Tabouret T; Debette-Gratien M; Abraham J; Mesturoux L; Marquet P; Alain S; Sautereau D; Essig M; Loustaud-Ratti V
    Liver Int; 2015 Oct; 35(10):2222-7. PubMed ID: 26104059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphomas associated with chronic hepatitis C virus infection: A prospective multicenter cohort study from the Rete Ematologica Lombarda (REL) clinical network.
    Rattotti S; Ferretti VV; Rusconi C; Rossi A; Fogazzi S; Baldini L; Pioltelli P; Balzarotti M; Farina L; Ferreri AJM; Laszlo D; Speziale V; Varettoni M; Sciarra R; Morello L; Tedeschi A; Frigeni M; Defrancesco I; Zerbi C; Flospergher E; Nizzoli ME; Morra E; Arcaini L;
    Hematol Oncol; 2019 Apr; 37(2):160-167. PubMed ID: 30726562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenetic mechanisms of hepatitis C virus-induced B-cell lymphomagenesis.
    Forghieri F; Luppi M; Barozzi P; Maffei R; Potenza L; Narni F; Marasca R
    Clin Dev Immunol; 2012; 2012():807351. PubMed ID: 22844326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral therapy of hepatitis C as curative treatment of indolent B-cell lymphoma.
    Merli M; Carli G; Arcaini L; Visco C
    World J Gastroenterol; 2016 Oct; 22(38):8447-8458. PubMed ID: 27784957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.